STLN
NASD Starling Oncology Inc.$6.48 ↓ -0.17 (-2.48%) Trading Down from the previous close of $6.64, $0.26 below the day’s high of $6.73
- YTD change
- +25.24%
- vs 20-day SMA
- +0.90%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
+1.47 (+28.43%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 9.2% away from all-time highs of $7.13
- STLN is up 25% since the beginning of the year
- STLN is up 25% over the past 12 months
- STLN is up 5% over the past 1 month
- 8% of all STLN investors are betting against STLN
STLN reads neutral: the 12-month move is +28.4%.
- Previous minute
- +$0.01
- Last hour
- +$0.06
- Last 5 days
- -5.20%
- vs 8-day SMA
- -4.25%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Starling Oncology, Inc. provides cancer care treatment services. It operates through the following business segments: Dispensary, Patient Care, and Clinical Trials and Other. The company was founded in 2007 and is headquartered in Cerritos, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.